Marvel BiosciencesMBCOF +4.74%33 Interest Coverage is 2.97 as of Apr. 2026, which is 100% below its 10-year median of 10,000.00. GuruFocus rates MBCOF with a GF Score™ of 33/100. The stock has 1 warning sign investors should review. Among 377 Biotechnology companies, Marvel Biosciences ranks worse than 265251.72% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Marvel Biosciences's
Operating Income
for the
three
months ended in Apr. 2026 was $0.09 Mil. Marvel Biosciences's Interest Expense for the
three
months ended in Apr. 2026 was $-0.03 Mil.
Marvel Biosciences's interest coverage for the quarter that ended in Apr. 2026 was 2.97.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Marvel Biosciences's Interest Coverage or its related term are showing as below:
MBCOF's Interest Coverage is not ranked *
in the Biotechnology industry.
Industry Median: 106.07 * Ranked among companies with meaningful Interest Coverage only.
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Marvel Biosciences Interest Coverage Related Terms
Marvel Biosciences Interest Coverage Historical Data
* Premium members only.
The historical data trend for Marvel Biosciences's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
MBCOF vs VRTX, REGN, ALNY: Interest Coverage Comparison
For the Biotechnology subindustry, Marvel Biosciences's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Marvel Biosciences Interest Coverage vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Marvel Biosciences's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Marvel Biosciences's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Marvel Biosciences (MBCOF) has a Interest Coverage of 2.97 as of Apr. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Marvel Biosciences and its competitors. This is 100% below median its historical median of 10,000.00. According to the industry distribution chart, Marvel Biosciences ranks #999999 out of 377 companies in the Biotechnology industry.
Is Marvel Biosciences' Interest Coverage too high?
Marvel Biosciences' current Interest Coverage of 2.97 is 100% below median its 10-year median of 10,000.00. The Biotechnology industry median Interest Coverage is 106.07. Marvel Biosciences' value of 2.97 is 97.2% below this industry median. Based on the distribution chart, Marvel Biosciences ranks #999999 out of 377 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Marvel Biosciences has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Marvel Biosciences' Interest Coverage compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Marvel Biosciences ranks #999999 out of 377 companies for Interest Coverage. This places Marvel Biosciences in the lower half of its industry. The industry median Interest Coverage is 106.07. Marvel Biosciences' value of 2.97 is 97.2% below this benchmark. While the company's 10-year median is 10,000.00 vs. the industry median of 106.07, Marvel Biosciences has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Biotechnology company?
The median Interest Coverage among Biotechnology companies is 106.07, based on 377 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Marvel Biosciences's current Interest Coverage of 2.97 is 97.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Marvel Biosciences and its competitors. For the Biotechnology industry, the median Interest Coverage is 106.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Marvel Biosciences's current Interest Coverage is 2.97, which is 100% below median its own 10-year median of 10,000.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Marvel Biosciences stock overvalued right now?
Marvel Biosciences (MBCOF) has a current Interest Coverage of 2.97. The current Interest Coverage is 2.97, which is 100% below median its 10-year median of 10,000.00 and 97.2% below the Biotechnology industry median of 106.07. Marvel Biosciences' overall GF Score™ is 33/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Marvel Biosciences (MBCOF), the current Interest Coverage is 2.97 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Marvel Biosciences Corp is a biotechnology company incorporated in Canada. The Company is currently a pre-clinical stage pharmaceutical development company that utilizes a drug redevelopment approach to identify and evaluate potential therapeutic compounds. Its activities mainly involve scientific research and pre-clinical studies aimed at determining viable active compounds for further drug development.
33GF Score
Get the complete analysis for MBCOF
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MBCOF has been successfully added to your 
